Acumen Pharmaceuticals, Inc. (ABOS) vs NervGen Pharma Corp. Common stock (NGEN)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NGEN
NervGen Pharma Corp. Common stock
$1.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABOS vs NGEN
growth of $100 · dividends reinvested · last 1yABOS +12.1% (+12.1%/yr)NGEN -57.6% (-57.6%/yr)ABOS compounded faster over this window
ABOS NGEN
ABOS vs NGEN: by the numbers
- •ABOS is the larger company ($147M vs $144M market cap).
Metrics side by side
Valuation
| Metric | ABOS | NGEN |
|---|---|---|
| P/B ratio | 2.56 | 11.81 |
Profitability
| Metric | ABOS | NGEN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -397.38% |
| ROIC | -118.67% | -223.90% |
Growth (annualized)
| Metric | ABOS | NGEN |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | N/A |
Go deeper
Dig into the metrics
Acumen Pharmaceuticals ROENervGen Pharma Corp. Common stock ROEAcumen Pharmaceuticals operating marginNervGen Pharma Corp. Common stock operating marginAcumen Pharmaceuticals revenue growthNervGen Pharma Corp. Common stock revenue growthAcumen Pharmaceuticals free cash flowNervGen Pharma Corp. Common stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.